United States Biotechnology & Medical Research

Coya Therapeutics Inc (COYA)

Track

Track

Coya Therapeutics Inc experienced notable insider activity during November 2024. Executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Medical Officer, executed multiple open-market purchases of company stock. These acquisitions represent the most recent trading events, reflecting a pattern of leadership investment in the firm's equity.
Ticker: COYA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Coya Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
SNYDER DAVID S Chief Financial Officer Officer
Transaction date
Purchase
Price
422.54
Quantity 21,850 -18.8%
Value US$4,028,931
1.1
Swaminathan Arun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
177.98
Quantity 53,382 -20.6%
Value US$388,878
1.1
Swaminathan Arun Chief Executive Officer Executive Director
Transaction date
Purchase
Price
363.57
Quantity 49,012 +30.1%
Value US$79,163
0.8
Grossman Fred Chief Medical Officer Officer
Transaction date
Purchase
Price
7.37
Quantity 2,710 +inf%
Value US$19,973
3.3
Lee Ann Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 1,000 +6.1%
Value US$3,620
Berman Howard Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
3.4
SNYDER DAVID S Chief Financial Officer Officer
Transaction date
Purchase
Price
0.00
Quantity 7,000
Value US$0
Hepner Adrian Chief Medical Officer Officer
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
0.6
GOLDSTEIN DOV A MD Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
Villalobos Anabella Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
3.3
Lee Ann Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 10,000
Value US$0
Garren Hideki Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 2,000
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-14 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
21,850 -18.8%
422.54
US$4,028,931 		21,850 -18.8% 422.54 US$4,028,931
2024-11-13 2024-11-13 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
53,382 -20.6%
177.98
US$388,878 		53,382 -20.6% 177.98 US$388,878
2024-11-12 2024-11-11 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
49,012 +30.1%
363.57
US$79,163 		49,012 +30.1% 363.57 US$79,163
2024-11-12 2024-11-11 B Purchase
0.8
Grossman Fred

Chief Medical Officer

Officer
2,710 +inf%
7.37
US$19,973 		2,710 +inf% 7.37 US$19,973
2024-03-05 2023-08-22 B Purchase
3.3
Lee Ann
Non-Executive Director
1,000 +6.1%
3.62
US$3,620 		1,000 +6.1% 3.62 US$3,620
2023-01-04 2023-01-03 B Purchase
Berman Howard

Chief Executive Officer

Executive Director Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
7,000
0.00
US$0 		7,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Hepner Adrian

Chief Medical Officer

Officer
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
0.6
GOLDSTEIN DOV A MD
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Villalobos Anabella
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.3
Lee Ann
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Garren Hideki
Non-Executive Director
2,000
0.00
US$0 		2,000 0.00 US$0
Explore more

More insider trading research around Coya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America